Sponge hemostatic agent NasoAid®

ENT surgery

70% collagen provides a highly porous sponge-like structure. 30% carboxymethyl cellulose: moisturizing, structural disintegration. High compressive strength, fully recovers within 30 seconds when wet. Structural integrity post-implantation maintained for 7 to 14 days. With 0.5mm macro-pores, it has a 35-fold (w/w) fluid absorption capacity. Collagen/cellulose composition for nasal dressing. Application NasoAid is suitable for nasal and sinus surgeries and can be used as an intranasal splint to reduce bleeding and edema, and prevent adhesion to the septum. Turbinate Reduction: Removal of part of the inferior turbinate to improve breathing. Septoplasty: Correction of a deviated septum by removing cartilage and securing mucosal flaps. Chronic Sinusitis Surgery: Removal of diseased tissue from the sinus to treat bacterial sinusitis and nasal polyps. Rhinoplasty: Reshaping the nasal tip. NasoAid stands out with its versatility and ability to adapt to various surgical needs, making it an ideal choice for both surgeons and patients seeking advanced nasal dressings. NasoAid is a next-generation nasal dressing composed of 70% bovine collagen and 30% carboxymethyl cellulose (CMC). The collagen is sourced from bovine tendon tissue in New Zealand and Australia, and meets FDA Guideline G95, ISO 22442, and ISO 13485 standards. Its natural polymer composition ensures biocompatibility and adheres to stringent quality requirements. Designed for use after nasal surgeries like septoplasty, turbinate reduction, chronic sinusitis treatment, and rhinoplasty, NasoAid nasal dressing effectively reduces bleeding, minimizes nasal adhesions, and promotes wound healing.